Baroreflex sensitivity impairment is associated with cardiac diastolic dysfunction in rats

Journal of Cardiac Failure

Volumn 17, Issue 6, 2011, Pages 519-525

  Mostarda, Cristiano ^a   Moraes Silva, Ivana Cinthya ^a   Moreira, Edson Dias ^a   Medeiros, Alessandra ^a,b   Piratello, Aline Cristina ^a   Consolim Colombo, Fernanda Marciano ^a   Caldini, Elia Garcia ^a   Brum, Patricia Chakur ^a   Krieger, Eduardo Moacyr ^a   Irigoyen, Maria Claudia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Baroreflex; cardiac hypertrophy; diastolic function; intracellular Ca 2+

Indexed keywords

CALCIUM; COLLAGEN; REGULATOR PROTEIN; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CAROTID SINUS DENERVATION; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE MASS; MALE; MORPHOMETRICS; NONHUMAN; PRESSORECEPTOR REFLEX; PRESSORECEPTOR REFLEX IMPAIRMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TACHYCARDIA;

ANIMALS; BAROREFLEX; DENERVATION; DISEASE MODELS, ANIMAL; HEART FAILURE, DIASTOLIC; MALE; PRESSORECEPTORS; RATS; RATS, WISTAR; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79957801810     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2011.02.007     Document Type: Article

References (31)

1. Miao CY, Xie HH, Zhan LS, Su DF. Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens 2006;24:1125-35.
2. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. ATRAMI (Autonomic Tone and Reflexes after Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998;14:478-84.
3. Mostarda C, Rodrigues B, Vane M, Moreira ED, Rosa KT, Moraes- Silva IC, et al. Autonomic impairment after myocardial infarction: role in cardiac remodeling and mortality. Clin Exp Pharmacol Physiol 2010;37:447-52.
4. La Rovere MT, Pinna GD, Maestri R, Robbi E, Caporotondi A, Guazzotti G, et al. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol 2009;53:193-9.
5. Liu AJ, Ma XJ, Shen FM, Liu JG, Chen H, Su DF. Arterial baroreflex: a novel target for preventing stroke in rat hypertension. Stroke 2007; 38:1916-23. (Pubitemid 46847269)
6. Sasaki S, Yoneda Y, Fujita H, Uchida A, Takenaka K, Takesako T, et al. Association of blood pressure variability with induction of atherosclerosis in cholesterol-fed rats. Am J Hypertens 1994;7:453-9. (Pubitemid 24170537)
7. Grassi G, Seravalle G, Quarti-Trevano F, dell'Oro R, Arenare F, Spaziani D, Mancia G. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction. Hypertension 2009;53:205-9.
8. Krieger EM. Neurogenic hypertension in the rat. Circ Res 1964;15: 511-21.
9. Soares PP, da Nóbrega AC, Ushizima MR, Irigoyen MC. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. Auton Neurosci 2004;113:24-31. (Pubitemid 39024510)
10. Mostarda C, Rogow A, Silva IC, de la Fuente RN, Jorge L, Rodrigues B, et al. Benefits of exercise training in diabetic rats persist after three weeks of detraining. Auton Neurosci 2009;145:11-6.
11. de Macedo Braga LM, Lacchini S, Schaan BD, Rodrigues B, Rosa K, de Angelis K, et al. In situ delivery of bone marrow cells and mesenchymal stem cells improves cardiovascular function in hypertensive rats submitted to myocardial infarction. J Biomed Sci 2008;15:365-74.
12. Bai X. Calculation of left ventricular relaxation time constant-Tau in humans by continuous-wave Doppler. Open Cardiovasc Med J 2008; 2:9-11.
13. Senzaki H, Fetics B, Chen CH, Kass DA. Comparison of ventricular pressure relaxation assessments in human heart failure: quantitative influence on load and drug sensitivity analysis. J Am Coll Cardiol 1999; 1(34):1529-36. (Pubitemid 29528668)
14. Montes GS. Structural biology of the fibres of the collagenous and elastic systems. Cell Biol Int 1996;20:15-27. (Pubitemid 26128875)
15. Medeiros A, Rolim NP, Oliveira RS, Rosa KT, Mattos KC, Casarini DE, et al. Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice. J Appl Physiol 2008;104:103-9.
16. Moraes-Silva IC, de la Fuente RN, Mostarda C, Rosa K, Flues K, Damaceno-Rodrigues NR, et al. Baroreflex deficit blunts exercise training-induced cardiovascular and autonomic adaptations in hypertensive rats. Clin Exp Pharmacol Physiol 2010;37:e114-20.
17. van Vliet BN, Chafe LL, Montani JP. Contribution of baroreceptors and chemoreceptors to ventricular hypertrophy produced by sinoaortic denervation in rats. J Physiol 1999;516(Pt 3):885-95. (Pubitemid 29201911)
18. Biaggioni I. The sympathetic nervous system and blood volume regulation: lessons from autonomic failure patients. Am J Med Sci 2007; 334:61-4. (Pubitemid 47067448)
19. Grassi G, Bombelli M, Seravalle G, dell'Oro R, Quarti-Trevano F. Diurnal blood pressure variation and sympathetic activity. Hypertens Res 2010;33:381-5.
20. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006;114:2138-47. (Pubitemid 44747894)
21. Post SR, Hammond HK, Insel PA. Betaadrenergic receptors and receptor signaling in heart failure. Annu Rev Pharmacol Toxicol 1999;39: 343-60. (Pubitemid 29222563)
22. Brum PC, Kosek J, Patterson A, Bernstein D, Kobilka B. Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol 2002;283:H1838-45.
23. Stern JE, Cardinali DP. Influence of the autonomic nervous system on calcium homeostasis in the rat. Biol Signals 1994;3:15-25. (Pubitemid 24196239)
24. Brum PC, Rolim NP, Bacurau AV, Medeiros A. Neurohumoral activation in heart failure: the role of adrenergic receptors. An Acad Bras Cienc 2006;78:485-503. (Pubitemid 44371940)
25. Mattiazzi A, Mundiña-Weilenmann C, Guoxiang C, Vittone L, Kranias E. Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. Cardiovasc Res 2005;68:366-75. (Pubitemid 41566556)
26. Neumann J, Boknik P, Herzig S, Schmitz W, Scholz H, Gupta RC, et al. Evidence for physiological functions of protein phosphatases in the heart: evaluation with okadaic acid. Am J Physiol 1993;265(1 Pt 2):H257-66.
27. Carr AN, Schmidt AG, Suzuki Y, del Monte F, Sato Y, Lanner C, et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol 2002;22:4124-35. (Pubitemid 34556583)
28. Martinka P, Fielitz J, Patzak A, Regitz-Zagrosek V, Persson PB, Stauss HM. Mechanisms of blood pressure variability-induced cardiac hypertrophy and dysfunction in mice with impaired baroreflex. Am J Physiol Regul Integr Comp Physiol 2005;288:R767-76.
29. Perrino C, Naga Prasad SV, Mao L, Noma T, Yan Z, Kim HS, et al. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest 2006;116:1547-60.
30. Kudo H, Kai H, Kajimoto H, Koga M, Takayama N, Mori T, et al. Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II systeme-mediated chronic inflammation. Hypertension 2009;54:832-8.
31. Irigoyen MC, Moreira ED, Ida F, Pires M, Cestari IA, Krieger EM. Changes of renal sympathetic activity in acute and chronic conscious sinoaortic denervated rats. Hypertension 1995;26(6 Pt 2):1111-6.